Free Trial

Universal Insurance (UVE) Financials

Universal Insurance logo
$39.13 -0.27 (-0.70%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$39.18 +0.06 (+0.15%)
As of 04:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Universal Insurance

Annual Income Statements for Universal Insurance

This table shows Universal Insurance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
106 99 107 117 47 19 20 -22 67 292 183
Consolidated Net Income / (Loss)
106 99 107 117 47 19 20 -22 67 59 183
Net Income / (Loss) Continuing Operations
106 99 107 117 47 19 20 -22 67 292 183
Total Pre-Tax Income
175 163 170 153 64 24 28 -27 88 85 243
Total Revenue
547 685 809 873 918 1,049 1,121 1,216 1,385 1,514 1,597
Net Interest Income / (Expense)
0.00 0.00 0.00 0.00 0.00 -0.10 -0.64 -6.61 -6.53 -6.48 -6.42
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
0.00 0.00 0.00 0.00 0.00 0.10 0.64 6.61 6.53 6.48 6.42
Long-Term Debt Interest Expense
- - - - - 0.10 0.64 6.61 6.53 6.48 6.42
Total Non-Interest Income
547 685 809 873 918 1,049 1,122 1,223 1,392 1,521 1,604
Other Service Charges
36 24 28 30 34 42 72 81 80 80 90
Net Realized & Unrealized Capital Gains on Investments
6.22 12 16 5.56 41 84 14 13 59 68 75
Premiums Earned
504 632 745 838 843 924 1,035 1,129 1,252 1,373 1,439
Total Non-Interest Expense
372 522 638 720 854 1,025 1,093 1,243 1,297 1,196 1,354
Property & Liability Insurance Claims
188 301 350 414 603 759 779 938 993 1,087 986
Insurance Policy Acquisition Costs
- - - - - - - - 208 0.00 250
Other Operating Expenses
184 221 288 305 251 266 314 305 96 109 118
Income Tax Expense
69 63 64 36 17 5.13 8.01 -4.99 22 26 60
Basic Earnings per Share
$3.06 $2.85 $3.07 $3.36 $1.37 $0.60 $0.65 ($0.72) $2.24 $2.07 $6.56
Weighted Average Basic Shares Outstanding
34.80M 34.92M 34.84M 34.86M 33.89M 31.88M 31.22M 30.75M 29.83M 28.50M 27.89M
Diluted Earnings per Share
$2.97 $2.79 $2.99 $3.27 $1.36 $0.60 $0.65 ($0.72) $2.22 $2.01 $6.32
Weighted Average Diluted Shares Outstanding
35.88M 35.65M 35.81M 35.79M 34.23M 31.97M 31.31M 30.75M 30.15M 29.27M 28.96M
Weighted Average Basic & Diluted Shares Outstanding
34.80M 34.90M 34.80M 34.80M 32.69M 31.21M 31.24M 30.43M 28.97M 28.10M 28.01M
Cash Dividends to Common per Share
$0.63 $0.69 $0.69 $0.73 $0.77 $0.77 $0.77 $0.77 $0.77 $0.77 $0.77

Quarterly Income Statements for Universal Insurance

This table shows Universal Insurance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-5.92 20 34 35 -16 6.02 41 35 40 67 54
Consolidated Net Income / (Loss)
-5.92 20 34 35 -16 6.02 41 35 40 67 54
Net Income / (Loss) Continuing Operations
-5.92 20 34 35 -16 6.02 41 35 40 67 54
Total Pre-Tax Income
-7.88 26 47 48 -18 7.35 55 46 53 88 72
Total Revenue
360 376 368 379 388 382 395 400 399 403 392
Net Interest Income / (Expense)
0.00 -3.27 0.00 -1.62 0.00 -3.24 0.00 0.00 -1.60 -4.82 -1.60
Total Interest Income
0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense
0.00 3.27 0.00 1.62 0.00 3.24 0.00 0.00 1.60 4.82 1.60
Long-Term Debt Interest Expense
- - - 1.62 - - - - 1.60 - 1.60
Total Non-Interest Income
360 380 368 380 388 385 395 400 401 408 394
Other Service Charges
18 21 17 20 20 23 23 23 22 21 22
Net Realized & Unrealized Capital Gains on Investments
11 23 17 16 22 14 16 16 19 23 15
Premiums Earned
331 335 334 345 346 348 356 360 360 363 357
Total Non-Interest Expense
368 350 320 331 406 374 339 354 347 315 320
Property & Liability Insurance Claims
288 275 240 244 317 287 251 260 252 223 228
Insurance Policy Acquisition Costs
- - - 57 59 - 61 62 64 - 64
Other Operating Expenses
78 77 79 30 28 89 27 30 31 -30 28
Income Tax Expense
-1.96 5.90 14 12 -1.96 1.33 14 11 13 22 17
Basic Earnings per Share
($0.20) $0.70 $1.17 $1.24 ($0.57) $0.23 $1.48 $1.25 $1.43 $2.40 $1.96
Weighted Average Basic Shares Outstanding
29.62M 29.83M 28.87M 28.60M 28.36M 28.50M 28.09M 27.97M 27.85M 27.89M 27.65M
Diluted Earnings per Share
($0.20) $0.70 $1.14 $1.21 ($0.57) $0.23 $1.44 $1.21 $1.38 $2.29 $1.88
Weighted Average Diluted Shares Outstanding
29.62M 30.15M 29.40M 29.31M 28.36M 29.27M 28.78M 29.07M 28.81M 28.96M 28.83M
Weighted Average Basic & Diluted Shares Outstanding
29.19M 28.97M 28.76M 28.48M 28.29M 28.10M 28.14M 28.32M 28.05M 28.01M 27.91M
Cash Dividends to Common per Share
$0.16 $0.29 $0.16 $0.16 $0.16 $0.29 $0.16 $0.16 $0.16 $0.29 $0.16

Annual Cash Flow Statements for Universal Insurance

This table details how cash moves in and out of Universal Insurance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
82 -91 108 -47 16 -4.87 73 138 8.60 -138 216
Net Cash From Operating Activities
219 121 245 230 85 29 234 325 71 137 381
Net Cash From Continuing Operating Activities
219 121 245 230 85 29 234 325 71 137 381
Net Income / (Loss) Continuing Operations
106 99 107 117 47 19 20 -22 67 59 183
Consolidated Net Income / (Loss)
106 99 107 117 47 19 20 -22 67 59 183
Provision For Loan Losses
0.61 0.41 0.50 0.00 0.45 -0.08 0.77 1.14 0.15 1.00 3.11
Depreciation Expense
2.03 3.24 4.06 4.82 4.96 5.11 6.91 7.30 7.31 6.12 6.44
Amortization Expense
2.35 3.63 4.00 1.48 1.66 4.63 9.79 8.83 7.27 4.46 1.33
Non-Cash Adjustments to Reconcile Net Income
11 9.03 2.82 -85 -9.99 -54 4.76 18 -7.28 0.81 3.15
Changes in Operating Assets and Liabilities, net
97 5.68 127 191 41 55 192 312 -3.31 66 185
Net Cash From Investing Activities
-83 -174 -86 -212 28 22 -229 -149 -15 -228 -114
Net Cash From Continuing Investing Activities
-83 -174 -86 -212 28 22 -229 -149 -15 -228 -114
Purchase of Property, Leasehold Improvements and Equipment
-12 -8.22 -4.62 -6.73 -11 -17 -7.23 -4.90 -4.02 -7.37 -4.44
Purchase of Investment Securities
-338 -392 -287 -470 -224 -1,191 -506 -277 -185 -391 -460
Sale of Property, Leasehold Improvements and Equipment
0.09 0.04 0.02 0.04 0.04 0.18 0.16 0.10 0.04 0.11 0.04
Sale and/or Maturity of Investments
267 226 206 264 263 1,230 283 133 173 170 351
Net Cash From Financing Activities
-55 -38 -52 -65 -97 -56 68 -37 -47 -47 -52
Net Cash From Continuing Financing Activities
-55 -38 -52 -65 -97 -56 68 -37 -47 -47 -52
Repayment of Debt
-8.47 -2.14 -2.17 -1.47 -1.47 -1.47 -4.84 -1.61 -1.47 -1.47 -1.47
Repurchase of Common Equity
-19 -8.51 -18 -25 -66 -29 -1.61 -12 -22 -22 -22
Payment of Dividends
-22 -24 -24 -26 -26 -25 -24 -24 -23 -22 -22
Other Financing Activities, Net
-6.32 -6.49 -7.22 -13 -3.47 -1.32 -1.06 -0.42 -0.34 -1.42 -6.11
Cash Interest Paid
0.96 0.42 0.35 0.35 0.25 0.10 0.13 5.80 5.82 5.77 5.71
Cash Income Taxes Paid
65 69 69 42 40 1.41 1.41 17 9.71 28 36

Quarterly Cash Flow Statements for Universal Insurance

This table details how cash moves in and out of Universal Insurance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-18 58 -83 -72 -83 101 -48 -71 -24 359 -34
Net Cash From Operating Activities
69 0.34 83 73 83 -101 187 106 62 26 155
Net Cash From Continuing Operating Activities
- 71 0.98 48 -50 140 0.00 - - 381 0.00
Net Income / (Loss) Continuing Operations
- 67 0.98 48 -50 61 0.00 - - 183 0.00
Net Cash From Investing Activities
0.93 -0.79 -74 -110 -23 -21 -42 -59 -8.69 -4.41 -20
Net Cash From Continuing Investing Activities
0.93 -0.79 -74 -110 -23 -21 -42 -59 -8.69 -4.41 -20
Purchase of Property, Leasehold Improvements and Equipment
-1.01 -1.15 -3.30 -1.52 -1.66 -0.89 -1.23 -0.98 -1.16 -1.08 -1.58
Purchase of Investment Securities
-39 -49 -111 -145 -96 -39 -77 -151 -120 -112 -131
Sale of Property, Leasehold Improvements and Equipment
0.01 0.01 0.05 0.04 0.01 0.01 0.01 0.00 0.01 0.02 0.04
Sale and/or Maturity of Investments
41 49 39 37 75 19 37 93 112 109 112
Net Cash From Financing Activities
-17 -13 -9.52 -10 -9.32 -18 -6.48 -12 -15 -18 -14
Net Cash From Continuing Financing Activities
-17 -13 -9.52 -10 -9.32 -18 -6.48 -12 -15 -18 -14
Repayment of Debt
-0.37 -0.37 -0.37 -0.37 -0.37 -0.37 -0.37 -0.37 -0.37 -0.37 -0.37
Repurchase of Common Equity
-12 -3.64 -4.51 -5.26 -4.44 -7.72 0.00 -7.43 -8.07 -6.87 -7.15
Payment of Dividends
-4.80 -8.60 -4.64 -4.64 -4.52 -8.53 -4.84 -4.52 -4.46 -8.35 -4.91
Other Financing Activities, Net
- -0.03 0.00 - -0.00 -1.42 -1.27 -0.02 -2.35 -2.47 -1.71

Annual Balance Sheets for Universal Insurance

This table presents Universal Insurance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
994 173 289 1,858 1,720 1,759 2,056 2,890 2,317 2,842 2,840
Cash and Due from Banks
197 106 213 166 182 167 251 389 397 259 409
Restricted Cash
2.64 2.64 2.64 2.64 2.64 13 2.64 2.64 2.64 2.64 69
Trading Account Securities
458 - - 884 899 905 1,088 1,100 1,145 1,347 1,516
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
33 - - 59 57 69 60 57 53 57 55
Unearned Premiums Asset
166 - - 621 432 443 492 352 532 968 600
Deferred Acquisition Cost
60 65 73 85 92 111 109 104 110 121 129
Other Assets
77 - - 40 55 52 55 886 76 87 62
Total Liabilities & Shareholders' Equity
994 534 781 1,858 1,720 1,759 2,056 2,890 2,317 2,842 2,840
Total Liabilities
700 534 781 1,357 1,226 1,309 1,626 2,602 1,975 2,469 2,289
Non-Interest Bearing Deposits
25 - - 26 31 50 54 55 49 46 62
Long-Term Debt
24 - - 11 9.93 8.46 104 103 102 101 100
Claims and Claim Expense
99 58 248 473 268 322 346 1,039 510 959 681
Unearned Premiums Liability
442 476 532 602 661 783 858 944 991 1,060 1,092
Other Long-Term Liabilities
110 - - 242 256 146 265 462 324 301 354
Commitments & Contingencies
0.00 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
293 0.00 0.00 502 494 449 430 288 341 373 551
Total Preferred & Common Equity
293 0.00 0.00 502 494 449 430 288 341 373 551
Preferred Stock
0.00 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
293 0.00 0.00 502 494 449 430 288 341 373 551
Common Stock
71 - - 87 97 104 109 113 116 122 125
Retained Earnings
307 - - 553 574 568 564 517 561 597 757
Treasury Stock
-81 - - -130 -197 -226 -227 -239 -261 -283 -305
Accumulated Other Comprehensive Income / (Loss)
-4.01 - - -8.01 20 3.34 -16 -104 -74 -63 -26

Quarterly Balance Sheets for Universal Insurance

This table presents Universal Insurance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
3,127 2,551 2,918 2,559 2,120 2,679 2,651 2,715 3,276 3,090 2,769
Cash and Due from Banks
307 330 292 344 396 283 334 398 367 405 596
Restricted Cash
2.70 2.64 69 69 2.64 69 69 2.64 69 69 2.64
Trading Account Securities
1,079 1,119 1,127 1,109 1,189 1,291 1,368 1,404 1,488 1,510 1,521
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
59 56 55 54 55 55 55 57 56 55 55
Unearned Premiums Asset
532 189 1,195 791 162 663 641 649 1,105 547 395
Deferred Acquisition Cost
112 98 107 115 107 117 125 116 125 133 126
Other Assets
1,035 756 73 77 208 200 58 89 66 370 75
Total Liabilities & Shareholders' Equity
3,127 2,551 2,918 2,559 2,120 2,679 2,651 2,715 3,276 3,090 2,769
Total Liabilities
2,866 2,229 2,583 2,257 1,755 2,285 2,250 2,292 2,818 2,595 2,185
Non-Interest Bearing Deposits
78 92 91 76 74 73 72 82 84 79 87
Long-Term Debt
103 103 102 102 102 102 101 101 101 101 100
Claims and Claim Expense
1,154 870 663 551 430 345 460 894 766 683 669
Unearned Premiums Liability
992 899 982 1,040 955 1,042 1,109 1,014 1,088 1,146 1,067
Other Long-Term Liabilities
540 265 745 488 195 723 508 201 780 586 262
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
261 322 335 302 365 393 400 422 458 495 585
Total Preferred & Common Equity
261 322 335 302 365 393 400 422 458 495 585
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
261 322 335 302 365 393 400 422 458 495 585
Common Stock
112 114 115 116 117 119 121 122 124 125 124
Retained Earnings
501 537 560 549 590 620 599 634 664 699 807
Treasury Stock
-237 -239 -245 -257 -265 -271 -275 -283 -290 -298 -312
Accumulated Other Comprehensive Income / (Loss)
-116 -90 -96 -107 -77 -76 -46 -51 -41 -31 -35

Annual Metrics And Ratios for Universal Insurance

This table displays calculated financial ratios and metrics derived from Universal Insurance's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 28,048,881.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 28,048,881.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 6.52
Growth Metrics
- - - - - - - - - - -
Revenue Growth
48.00% 25.39% 17.99% 7.94% 5.16% 14.29% 6.89% 8.46% 13.90% 9.31% 5.51%
EBITDA Growth
36.17% -5.38% 5.18% -10.85% -55.94% -51.57% 32.81% -124.66% 1,025.41% -7.52% -23.67%
EBIT Growth
37.16% -6.94% 4.67% -10.33% -58.45% -61.85% 17.26% -195.90% 424.25% -4.23% -23.58%
NOPAT Growth
45.89% -6.64% 7.57% 9.46% -60.26% -58.93% 6.82% -193.46% 450.36% -11.81% 210.47%
Net Income Growth
45.89% -6.64% 7.57% 9.46% -60.26% -58.93% 6.82% -209.07% 400.23% -11.81% 210.47%
EPS Growth
42.79% -6.06% 7.17% 9.36% -58.41% -55.88% 8.33% -210.77% 408.33% -9.46% 214.43%
Operating Cash Flow Growth
77.77% -44.64% 101.83% -6.08% -63.24% -65.31% 698.62% 38.46% -78.13% 93.54% 177.74%
Free Cash Flow Firm Growth
7.04% 1,900.42% -69.43% -473.52% 106.28% 17.05% -184.73% 323.77% -88.53% 95.54% -78.63%
Invested Capital Growth
27.10% -213.82% -36.21% 204.34% -1.79% -9.15% 16.53% -26.76% 13.47% 7.04% 37.31%
Revenue Q/Q Growth
11.78% 2.47% 10.89% 0.85% -10.65% -33.40% 147.42% 2.30% 3.82% 0.35% 1.47%
EBITDA Q/Q Growth
9.35% -9.72% 32.63% -28.53% -42.19% -94.46% 107.98% 89.89% 27.52% -7.73% 54.88%
EBIT Q/Q Growth
6.68% -13.38% 26.64% -31.36% -47.65% -96.05% 105.03% 75.22% 9.45% -17.98% 50.08%
NOPAT Q/Q Growth
8.32% -13.49% 27.01% -26.82% -48.93% 253.13% -59.87% 78.12% -7.11% -19.18% 49.49%
Net Income Q/Q Growth
8.32% -13.49% 27.01% -26.80% -48.95% 233.67% -59.87% 76.69% -7.11% -19.18% 49.49%
EPS Q/Q Growth
8.00% -13.35% 27.23% -27.01% -48.29% 287.50% -60.61% 76.70% -5.93% -18.95% 48.36%
Operating Cash Flow Q/Q Growth
2,176.82% -44.64% -39.89% 25.56% 35.92% -85.44% 80.59% 76.79% -58.74% -42.54% 50.15%
Free Cash Flow Firm Q/Q Growth
1,185.32% 1,775.27% 508.39% -1,841.82% 2.07% -21.63% -268.38% 143.19% -55.45% 210.63% -79.09%
Invested Capital Q/Q Growth
0.61% -192.88% -213.35% -5.48% -13.02% -5.35% 6.33% 7.44% 9.81% -5.42% 9.37%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
32.83% 24.77% 22.08% 18.24% 7.64% 3.24% 4.02% -0.91% 7.43% 6.29% 15.70%
EBIT Margin
32.02% 23.77% 21.08% 17.52% 6.92% 2.31% 2.53% -2.24% 6.38% 5.59% 15.22%
Profit (Net Income) Margin
19.48% 14.51% 13.22% 13.41% 5.07% 1.82% 1.82% -1.83% 4.82% 3.89% 11.45%
Tax Burden Percent
60.84% 61.03% 62.72% 76.57% 73.23% 78.85% 71.82% 81.69% 75.64% 69.65% 75.27%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
39.16% 38.97% 37.28% 23.43% 26.77% 21.15% 28.18% 0.00% 24.36% 30.35% 24.73%
Return on Invested Capital (ROIC)
37.58% 0.00% 0.00% 1,096.96% 9.15% 3.97% 4.12% -4.13% 16.03% 12.84% 32.50%
ROIC Less NNEP Spread (ROIC-NNEP)
37.58% 0.00% 0.00% 1,096.96% 9.15% 3.97% 4.12% -7.21% 16.03% 12.84% 32.50%
Return on Net Nonoperating Assets (RNNOA)
4.01% 0.00% 0.00% -1,050.29% 0.20% 0.08% 0.53% -2.08% 5.22% 3.65% 7.09%
Return on Equity (ROE)
41.59% 67.84% 0.00% 46.67% 9.34% 4.05% 4.64% -6.20% 21.24% 16.49% 39.59%
Cash Return on Invested Capital (CROIC)
13.72% 0.00% 0.00% -173.02% 10.96% 13.56% -11.15% 26.76% 3.40% 6.04% 1.05%
Operating Return on Assets (OROA)
18.37% 27.92% 73.73% 14.24% 3.55% 1.39% 1.49% -1.10% 3.39% 3.28% 8.56%
Return on Assets (ROA)
11.18% 17.04% 46.25% 10.90% 2.60% 1.10% 1.07% -0.90% 2.57% 2.28% 6.44%
Return on Common Equity (ROCE)
40.05% 67.84% 0.00% 46.67% 9.34% 4.05% 4.64% -6.20% 21.24% 16.49% 39.59%
Return on Equity Simple (ROE_SIMPLE)
36.33% 0.00% 0.00% 23.33% 9.42% 4.25% 4.75% -7.73% 19.58% 15.79% 33.20%
Net Operating Profit after Tax (NOPAT)
106 99 107 117 47 19 20 -19 67 59 183
NOPAT Margin
19.48% 14.51% 13.22% 13.41% 5.07% 1.82% 1.82% -1.57% 4.82% 3.89% 11.45%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.08% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
67.98% 76.23% 78.92% 82.48% 93.08% 97.69% 97.47% 102.24% 93.62% 94.41% 84.78%
Earnings before Interest and Taxes (EBIT)
175 163 170 153 64 24 28 -27 88 85 243
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
179 170 179 159 70 34 45 -11 103 95 251
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.01 0.00 0.00 2.04 1.49 0.87 1.08 1.03 1.32 1.60 1.72
Price to Tangible Book Value (P/TBV)
2.01 0.00 0.00 2.04 1.49 0.87 1.08 1.03 1.32 1.60 1.72
Price to Revenue (P/Rev)
1.08 1.07 0.88 1.17 0.80 0.37 0.41 0.24 0.32 0.39 0.59
Price to Earnings (P/E)
5.52 7.36 6.67 8.74 15.84 20.56 22.66 0.00 6.72 10.11 5.18
Dividend Yield
2.91% 2.63% 2.66% 2.05% 2.88% 5.11% 4.11% 6.57% 3.96% 3.66% 2.28%
Earnings Yield
18.12% 13.58% 15.00% 11.44% 6.31% 4.86% 4.41% 0.00% 14.87% 9.89% 19.30%
Enterprise Value to Invested Capital (EV/IC)
1.30 0.00 0.00 1.69 1.12 0.48 0.59 0.02 0.34 0.92 0.88
Enterprise Value to Revenue (EV/Rev)
0.75 0.91 0.61 0.99 0.61 0.21 0.28 0.01 0.11 0.29 0.36
Enterprise Value to EBITDA (EV/EBITDA)
2.30 3.67 2.78 5.44 8.01 6.52 6.94 0.00 1.47 4.57 2.28
Enterprise Value to EBIT (EV/EBIT)
2.36 3.83 2.92 5.66 8.85 9.13 11.02 0.00 1.71 5.14 2.35
Enterprise Value to NOPAT (EV/NOPAT)
3.87 6.27 4.65 7.39 12.08 11.58 15.34 0.00 2.27 7.38 3.12
Enterprise Value to Operating Cash Flow (EV/OCF)
1.88 5.14 2.03 3.76 6.64 7.54 1.34 0.03 2.13 3.17 1.50
Enterprise Value to Free Cash Flow (EV/FCFF)
10.60 0.80 2.09 0.00 10.09 3.39 0.00 0.07 10.67 15.68 96.27
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.08 0.00 0.00 0.02 0.02 0.02 0.24 0.36 0.30 0.27 0.18
Long-Term Debt to Equity
0.08 0.00 0.00 0.02 0.02 0.02 0.24 0.36 0.30 0.27 0.18
Financial Leverage
0.11 -1.15 0.00 -0.96 0.02 0.02 0.13 0.29 0.33 0.28 0.22
Leverage Ratio
3.72 3.98 0.00 4.28 3.59 3.69 4.34 6.89 8.28 7.22 6.15
Compound Leverage Factor
3.72 3.98 0.00 4.28 3.59 3.69 4.34 6.89 8.28 7.22 6.15
Debt to Total Capital
7.58% 0.00% 0.00% 2.22% 1.97% 1.85% 19.44% 26.31% 23.01% 21.34% 15.42%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
7.58% 0.00% 0.00% 2.22% 1.97% 1.85% 19.44% 26.31% 23.01% 21.34% 15.42%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
92.42% 0.00% 0.00% 97.78% 98.03% 98.15% 80.56% 73.69% 76.99% 78.66% 84.58%
Debt to EBITDA
0.13 0.00 0.00 0.07 0.14 0.25 2.30 -9.24 0.99 1.06 0.40
Net Debt to EBITDA
-0.98 0.00 0.00 -0.99 -2.49 -5.05 -3.31 25.94 -2.89 -1.69 -1.50
Long-Term Debt to EBITDA
0.13 0.00 0.00 0.07 0.14 0.25 2.30 -9.24 0.99 1.06 0.40
Debt to NOPAT
0.23 0.00 0.00 0.10 0.21 0.44 5.08 -5.39 1.53 1.72 0.55
Net Debt to NOPAT
-1.65 0.00 0.00 -1.35 -3.76 -8.97 -7.32 15.13 -4.46 -2.73 -2.06
Long-Term Debt to NOPAT
0.23 0.00 0.00 0.10 0.21 0.44 5.08 -5.39 1.53 1.72 0.55
Noncontrolling Interest Sharing Ratio
3.71% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
39 778 238 -888 56 65 -55 124 14 28 5.93
Operating Cash Flow to CapEx
1,860.91% 1,482.79% 5,332.10% 3,436.45% 750.25% 172.29% 3,317.92% 6,757.91% 1,784.54% 1,891.98% 8,674.24%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 686.46 -86.60 18.71 2.17 4.28 0.92
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 308.93 367.36 49.10 10.87 21.21 59.40
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 129.62 356.29 48.38 10.26 20.09 58.72
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.57 1.17 3.50 0.81 0.51 0.60 0.59 0.49 0.53 0.59 0.56
Fixed Asset Turnover
21.67 0.00 0.00 0.00 15.77 16.69 17.48 20.84 25.12 27.50 28.58
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
317 -361 -492 513 504 458 533 391 443 474 652
Invested Capital Turnover
1.93 -31.27 -1.90 81.79 1.81 2.18 2.26 2.63 3.32 3.30 2.84
Increase / (Decrease) in Invested Capital
68 -678 -131 1,005 -9.20 -46 76 -143 53 31 177
Enterprise Value (EV)
412 624 497 865 562 221 313 8.51 151 435 571
Market Capitalization
588 732 713 1,023 737 393 462 297 449 596 948
Book Value per Share
$8.23 $0.00 $0.00 $14.36 $14.87 $14.34 $13.79 $9.44 $11.69 $13.20 $19.65
Tangible Book Value per Share
$8.23 $0.00 $0.00 $14.36 $14.87 $14.34 $13.79 $9.44 $11.69 $13.20 $19.65
Total Capital
317 0.00 0.00 513 504 458 533 391 443 474 652
Total Debt
24 0.00 0.00 11 9.93 8.46 104 103 102 101 100
Total Long-Term Debt
24 0.00 0.00 11 9.93 8.46 104 103 102 101 100
Net Debt
-176 -108 -216 -158 -175 -171 -149 -289 -298 -161 -377
Capital Expenditures (CapEx)
12 8.19 4.60 6.70 11 17 7.06 4.80 3.98 7.26 4.40
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.18 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
24 -361 -492 11 9.93 8.46 104 103 102 101 100
Total Depreciation and Amortization (D&A)
4.39 6.87 8.06 6.30 6.62 9.74 17 16 15 11 7.78
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.06 $2.85 $3.07 $3.36 $1.37 $0.60 $0.65 ($0.72) $2.24 $2.07 $6.56
Adjusted Weighted Average Basic Shares Outstanding
34.80M 34.92M 34.84M 34.86M 33.89M 31.88M 31.22M 30.75M 29.83M 28.50M 27.89M
Adjusted Diluted Earnings per Share
$2.97 $2.79 $2.99 $3.27 $1.36 $0.60 $0.65 ($0.72) $2.22 $2.01 $6.32
Adjusted Weighted Average Diluted Shares Outstanding
35.88M 35.65M 35.81M 35.79M 34.23M 31.97M 31.31M 30.75M 30.15M 29.27M 28.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $1.37 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
35.11M 35.17M 34.86M 34.90M 32.69M 31.21M 31.24M 30.43M 28.97M 28.10M 28.01M
Normalized Net Operating Profit after Tax (NOPAT)
106 99 107 117 47 19 20 -19 67 59 183
Normalized NOPAT Margin
19.48% 14.51% 13.22% 13.41% 5.07% 1.82% 1.82% -1.57% 4.82% 3.89% 11.45%
Pre Tax Income Margin
32.02% 23.77% 21.08% 17.52% 6.92% 2.31% 2.53% -2.24% 6.38% 5.59% 15.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 255.06 44.53 -4.12 13.53 13.07 37.85
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 201.11 31.99 -2.89 10.23 9.10 28.49
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 75.76 33.46 -4.85 12.92 11.94 37.16
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 21.80 20.91 -3.61 9.62 7.98 27.80
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
20.94% 24.35% 22.45% 21.80% 56.15% 128.54% 118.59% -106.86% 34.85% 37.89% 12.12%
Augmented Payout Ratio
38.45% 32.91% 39.42% 43.39% 198.44% 279.92% 126.48% -159.17% 67.81% 75.07% 24.35%

Quarterly Metrics And Ratios for Universal Insurance

This table displays calculated financial ratios and metrics derived from Universal Insurance's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - 28,048,881.00 28,008,189.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 28,048,881.00 28,008,189.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 2.37 1.94
Growth Metrics
- - - - - - - - - - -
Revenue Growth
15.10% 15.67% 17.91% 12.51% 7.19% 1.39% 7.31% 5.69% 3.05% 6.09% -0.73%
EBITDA Growth
92.77% 41.77% 44.81% 31.94% -190.15% -71.64% 16.21% 0.19% 419.78% -63.27% 25.63%
EBIT Growth
90.88% 41.77% 44.81% 27.61% -130.07% -71.64% 16.79% -3.17% 391.22% -63.27% 29.28%
NOPAT Growth
91.55% -20.36% 39.23% 23.98% -130.07% -69.91% 23.12% -0.91% 413.97% 1,006.50% 31.01%
Net Income Growth
91.82% -20.36% 39.23% 23.98% -173.25% -69.91% 23.12% -0.91% 346.43% 1,006.50% 31.01%
EPS Growth
91.53% -16.67% 44.30% 30.11% -185.00% -67.14% 26.32% 0.00% 342.11% 895.65% 30.56%
Operating Cash Flow Growth
3,153.86% -99.66% 264.98% 41.62% 19.35% -29,905.59% 125.25% 45.20% -24.45% 125.74% -17.11%
Free Cash Flow Firm Growth
-162.68% -119.45% -108.48% -136.57% -142.65% 22.88% -83.95% -28.27% 51.02% -338.72% -591.30%
Invested Capital Growth
11.03% 13.47% 9.92% 13.23% 24.27% 7.04% 12.21% 12.89% 18.74% 37.31% 30.87%
Revenue Q/Q Growth
6.54% 4.53% -2.66% 3.79% 1.50% -1.13% 3.48% 1.34% -0.19% 0.93% -2.76%
EBITDA Q/Q Growth
-116.64% 514.60% 147.91% 4.30% -136.59% 140.53% 676.96% -15.90% 9.97% 67.59% -18.95%
EBIT Q/Q Growth
-120.98% 428.75% 147.91% 0.89% -137.83% 140.53% 655.02% -16.36% 13.78% 67.59% -18.95%
NOPAT Q/Q Growth
-119.30% 462.70% 68.29% 5.23% -135.82% 147.44% 588.58% -15.31% 13.50% 67.18% -18.47%
Net Income Q/Q Growth
-120.71% 438.11% 68.29% 5.23% -145.64% 137.23% 588.58% -15.31% 13.50% 67.18% -18.47%
EPS Q/Q Growth
-121.51% 450.00% 62.86% 6.14% -147.11% 140.35% 526.09% -15.97% 14.05% 65.94% -17.90%
Operating Cash Flow Q/Q Growth
34.02% -99.51% 24,287.06% -11.77% 12.94% -222.65% 284.30% -43.13% -41.24% -58.22% 493.64%
Free Cash Flow Firm Q/Q Growth
-174.50% 28.43% 74.15% -165.31% -394.34% 77.25% 38.34% -85.00% -88.77% -103.73% 2.84%
Invested Capital Q/Q Growth
-7.63% 9.81% 5.23% 6.08% 1.38% -5.42% 10.32% 6.73% 6.63% 9.37% 5.14%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
-1.73% 6.88% 12.96% 13.03% -4.70% 1.92% 14.45% 11.99% 13.21% 21.94% 18.29%
EBIT Margin
-2.19% 6.88% 12.96% 12.60% -4.70% 1.92% 14.04% 11.59% 13.21% 21.94% 18.29%
Profit (Net Income) Margin
-1.64% 5.31% 9.19% 9.31% -4.19% 1.58% 10.49% 8.77% 9.97% 16.52% 13.85%
Tax Burden Percent
75.09% 77.23% 70.88% 73.93% 89.19% 81.93% 74.72% 75.65% 75.47% 75.28% 75.73%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 22.77% 29.12% 26.07% 0.00% 18.07% 25.28% 24.35% 24.53% 24.72% 24.27%
Return on Invested Capital (ROIC)
-5.33% 17.65% 29.72% 29.64% -10.96% 5.20% 32.67% 26.01% 28.62% 46.87% 36.55%
ROIC Less NNEP Spread (ROIC-NNEP)
-5.72% 17.65% 29.72% 29.64% -14.37% 5.20% 32.67% 26.01% 28.62% 46.87% 36.55%
Return on Net Nonoperating Assets (RNNOA)
-2.09% 5.74% 8.85% 8.31% -4.17% 1.48% 8.42% 6.19% 6.46% 10.23% 7.31%
Return on Equity (ROE)
-7.41% 23.39% 38.56% 37.95% -15.13% 6.68% 41.09% 32.20% 35.07% 57.10% 43.86%
Cash Return on Invested Capital (CROIC)
8.30% 3.40% 7.68% 5.44% -5.54% 6.04% 1.97% 0.49% 5.17% 1.05% 5.66%
Operating Return on Assets (OROA)
-1.03% 3.66% 8.00% 6.68% -2.72% 1.13% 8.95% 6.08% 7.25% 12.34% 10.64%
Return on Assets (ROA)
-0.77% 2.83% 5.67% 4.94% -2.43% 0.93% 6.69% 4.60% 5.47% 9.29% 8.05%
Return on Common Equity (ROCE)
-7.41% 23.39% 38.56% 37.95% -15.13% 6.68% 41.09% 32.20% 35.07% 57.10% 43.86%
Return on Equity Simple (ROE_SIMPLE)
23.86% 0.00% 20.93% 21.15% 18.22% 0.00% 15.79% 14.50% 24.72% 0.00% 33.49%
Net Operating Profit after Tax (NOPAT)
-5.51 20 34 35 -13 6.02 41 35 40 67 54
NOPAT Margin
-1.53% 5.31% 9.19% 9.31% -3.29% 1.58% 10.49% 8.77% 9.97% 16.52% 13.85%
Net Nonoperating Expense Percent (NNEP)
0.39% 0.00% 0.00% 0.00% 3.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
102.19% 93.12% 87.04% 87.40% 104.70% 98.08% 85.96% 88.41% 86.79% 78.06% 81.71%
Earnings before Interest and Taxes (EBIT)
-7.88 26 47 48 -18 7.35 55 46 53 88 72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-6.25 26 47 50 -18 7.35 57 48 53 88 72
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.34 1.32 1.59 1.36 1.58 1.60 1.58 1.70 1.50 1.72 1.64
Price to Tangible Book Value (P/TBV)
1.34 1.32 1.59 1.36 1.58 1.60 1.58 1.70 1.50 1.72 1.64
Price to Revenue (P/Rev)
0.30 0.32 0.40 0.36 0.42 0.39 0.43 0.50 0.47 0.59 0.60
Price to Earnings (P/E)
5.62 6.72 7.59 6.43 8.66 10.11 9.98 11.76 6.09 5.18 4.89
Dividend Yield
4.76% 3.96% 3.05% 3.28% 2.75% 3.66% 3.25% 2.78% 2.93% 2.28% 2.25%
Earnings Yield
17.79% 14.87% 13.18% 15.54% 11.55% 9.89% 10.02% 8.51% 16.43% 19.30% 20.47%
Enterprise Value to Invested Capital (EV/IC)
0.23 0.34 0.60 0.58 0.66 0.92 0.70 0.80 0.62 0.88 0.67
Enterprise Value to Revenue (EV/Rev)
0.07 0.11 0.20 0.19 0.22 0.29 0.24 0.29 0.24 0.36 0.29
Enterprise Value to EBITDA (EV/EBITDA)
1.16 1.47 2.74 2.51 3.20 4.57 3.95 4.89 2.29 2.28 1.77
Enterprise Value to EBIT (EV/EBIT)
1.16 1.71 2.74 2.51 3.20 5.14 3.95 4.89 2.29 2.35 1.77
Enterprise Value to NOPAT (EV/NOPAT)
1.30 2.27 3.70 3.42 4.53 7.38 5.49 6.71 3.03 3.12 2.34
Enterprise Value to Operating Cash Flow (EV/OCF)
0.54 2.13 1.38 1.26 1.38 3.17 1.52 1.62 1.46 1.50 1.31
Enterprise Value to Free Cash Flow (EV/FCFF)
2.94 10.67 8.24 11.23 0.00 15.68 37.55 172.77 13.10 96.27 13.41
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.34 0.30 0.28 0.26 0.25 0.27 0.24 0.22 0.20 0.18 0.17
Long-Term Debt to Equity
0.34 0.30 0.28 0.26 0.25 0.27 0.24 0.22 0.20 0.18 0.17
Financial Leverage
0.37 0.33 0.30 0.28 0.29 0.28 0.26 0.24 0.23 0.22 0.20
Leverage Ratio
10.11 8.28 6.80 7.69 7.42 7.22 6.14 7.00 6.41 6.15 5.45
Compound Leverage Factor
10.11 8.28 6.80 7.69 7.42 7.22 6.14 7.00 6.41 6.15 5.45
Debt to Total Capital
25.32% 23.01% 21.83% 20.54% 20.22% 21.34% 19.31% 18.05% 16.90% 15.42% 14.64%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
25.32% 23.01% 21.83% 20.54% 20.22% 21.34% 19.31% 18.05% 16.90% 15.42% 14.64%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
74.69% 76.99% 78.17% 79.46% 79.78% 78.66% 80.69% 81.95% 83.10% 84.58% 85.36%
Debt to EBITDA
1.27 0.99 0.99 0.90 0.98 1.06 1.09 1.11 0.62 0.40 0.39
Net Debt to EBITDA
-3.85 -2.89 -2.88 -2.21 -2.92 -1.69 -3.24 -3.68 -2.31 -1.50 -1.92
Long-Term Debt to EBITDA
1.27 0.99 0.99 0.90 0.98 1.06 1.09 1.11 0.62 0.40 0.39
Debt to NOPAT
1.42 1.53 1.33 1.22 1.39 1.72 1.51 1.52 0.82 0.55 0.51
Net Debt to NOPAT
-4.32 -4.46 -3.89 -3.01 -4.13 -2.73 -4.49 -5.04 -3.05 -2.06 -2.54
Long-Term Debt to NOPAT
1.42 1.53 1.33 1.22 1.39 1.72 1.51 1.52 0.82 0.55 0.51
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-46 -33 -8.44 -22 -111 -25 -16 -29 -54 -110 -107
Operating Cash Flow to CapEx
6,943.93% 29.77% 2,552.83% 4,959.80% 4,986.36% -11,515.80% 15,334.07% 10,905.85% 5,446.86% 2,460.38% 10,040.34%
Free Cash Flow to Firm to Interest Expense
0.00 -9.99 -5.20 0.00 -68.36 -7.78 0.00 0.00 -33.81 -22.92 -67.27
Operating Cash Flow to Interest Expense
0.00 0.10 51.12 0.00 51.03 -31.33 0.00 0.00 38.94 5.41 97.07
Operating Cash Flow Less CapEx to Interest Expense
0.00 -0.25 49.12 0.00 50.01 -31.60 0.00 0.00 38.23 5.19 96.10
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.47 0.53 0.62 0.53 0.58 0.59 0.64 0.52 0.55 0.56 0.58
Fixed Asset Turnover
23.65 25.12 26.02 26.97 27.62 27.50 27.66 28.23 28.54 28.58 28.66
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
404 443 466 495 502 474 523 559 596 652 685
Invested Capital Turnover
3.48 3.32 3.23 3.18 3.33 3.30 3.11 2.97 2.87 2.84 2.64
Increase / (Decrease) in Invested Capital
40 53 42 58 98 31 57 64 94 177 162
Enterprise Value (EV)
94 151 282 285 330 435 366 446 371 571 459
Market Capitalization
404 449 579 535 631 596 666 780 745 948 957
Book Value per Share
$10.02 $11.69 $12.59 $13.67 $14.05 $13.20 $15.03 $16.27 $17.48 $19.65 $20.88
Tangible Book Value per Share
$10.02 $11.69 $12.59 $13.67 $14.05 $13.20 $15.03 $16.27 $17.48 $19.65 $20.88
Total Capital
404 443 466 495 502 474 523 559 596 652 685
Total Debt
102 102 102 102 101 101 101 101 101 100 100
Total Long-Term Debt
102 102 102 102 101 101 101 101 101 100 100
Net Debt
-311 -298 -297 -250 -301 -161 -300 -335 -374 -377 -498
Capital Expenditures (CapEx)
1.00 1.14 3.25 1.48 1.66 0.88 1.22 0.97 1.15 1.06 1.54
Net Nonoperating Expense (NNE)
0.40 0.00 0.00 0.00 3.48 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
102 102 102 102 101 101 101 101 101 100 100
Total Depreciation and Amortization (D&A)
1.63 0.00 0.00 1.62 0.00 0.00 1.61 1.61 0.00 0.00 0.00
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.20) $0.70 $1.17 $1.24 ($0.57) $0.23 $1.48 $1.25 $1.43 $2.40 $1.96
Adjusted Weighted Average Basic Shares Outstanding
29.62M 29.83M 28.87M 28.60M 28.36M 28.50M 28.09M 27.97M 27.85M 27.89M 27.65M
Adjusted Diluted Earnings per Share
($0.20) $0.70 $1.14 $1.21 ($0.57) $0.23 $1.44 $1.21 $1.38 $2.29 $1.88
Adjusted Weighted Average Diluted Shares Outstanding
29.62M 30.15M 29.40M 29.31M 28.36M 29.27M 28.78M 29.07M 28.81M 28.96M 28.83M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
29.19M 28.97M 28.76M 28.48M 28.29M 28.10M 28.14M 28.32M 28.05M 28.01M 27.91M
Normalized Net Operating Profit after Tax (NOPAT)
-5.51 20 34 35 -13 6.02 41 35 40 67 54
Normalized NOPAT Margin
-1.53% 5.31% 9.19% 9.31% -3.29% 1.58% 10.49% 8.77% 9.97% 16.52% 13.85%
Pre Tax Income Margin
-2.19% 6.88% 12.96% 12.60% -4.70% 1.92% 14.04% 11.59% 13.21% 21.94% 18.29%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 7.93 29.28 0.00 -11.19 2.27 0.00 0.00 32.92 18.35 44.95
NOPAT to Interest Expense
0.00 6.12 20.75 0.00 -7.84 1.86 0.00 0.00 24.85 13.82 34.04
EBIT Less CapEx to Interest Expense
0.00 7.58 27.27 0.00 -12.22 2.00 0.00 0.00 32.21 18.13 43.98
NOPAT Less CapEx to Interest Expense
0.00 5.77 18.75 0.00 -8.86 1.59 0.00 0.00 24.13 13.60 33.07
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
32.78% 34.85% 30.07% 27.27% 30.72% 37.89% 33.77% 33.75% 18.26% 12.12% 11.36%
Augmented Payout Ratio
60.90% 67.81% 64.84% 58.17% 55.18% 75.07% 59.86% 63.24% 37.23% 24.35% 26.43%

Financials Breakdown Chart

Key Financial Trends

Universal Insurance (NYSE: UVE) has delivered a solid end to 2025 with improving profitability, strong non-interest income, and healthy operating cash flow. In Q4 2025, the company posted net income of $66.6 million on revenue of about $403.1 million, driven by premiums earned and gains on investments. Cash flow remained favorable, with continuing operating cash flow near $381.5 million in that quarter. Over the last four years, revenue has trended higher and the company has shown an expanding earnings base, even as insurance liabilities and some interest-related costs remain a consideration for investors.

  • Q4 2025 net income attributable to common shareholders of $66.6 million and basic/diluted EPS of $2.40/$2.29, marking a strong quarterly profit recovery vs prior periods.
  • Total revenue for Q4 2025 reached about $403.1 million, with non-interest income at $407.9 million and premiums earned at $363.4 million, indicating a favorable mix of revenue sources beyond net interest income.
  • Four-year revenue trend shows growth: approximately $292–325 million in 2022–2023 levels rising to about $381–403 million in 2024–2025, illustrating a stable top-line uptrend.
  • Q4 2025 cash flow signals: net cash from continuing operating activities about $381.5 million and net change in cash around $359.0 million, suggesting solid liquidity and cash generation capabilities.
  • Cash dividends per share of $0.29 indicate ongoing capital return to shareholders, complementing earnings strength.
  • Net interest expense in some quarters remains a drag (for example, Q4 2025 net interest expense of about $4.82 million and negative net interest income in several periods), but the scale is relatively small versus total revenue and non-interest income.
  • Balance sheet size is meaningful, with total assets around $3.0–3.3 billion in 2024–2025 periods, reflecting a solid asset base.
  • Liability profile includes substantial property & liability insurance claims and unearned premiums liabilities, implying ongoing reserve needs and potential sensitivity to claims volatility.
  • Long-term debt remains modest (roughly $100 million range across recent quarters), indicating manageable leverage for a P&C insurer.
  • Net interest income has shown periodic weakness (negative in multiple quarters, including Q4 2025), which can compress margins if interest rates or investment spreads worsen.

Trend context and what to watch:

  • Over the four-year span, UVE’s revenue has trended upward, with 2025 quarterly results continuing to show revenue around the high $300s to low $400s million range, signaling a stable growth trajectory.
  • Net income has improved meaningfully by late 2025, with Q4 2025 net income of $66.6 million versus prior-year quarters that were lower, reflecting better underwriting and investment outcomes.
  • Non-interest income is a key driver, led by premiums earned and investment gains, helping offset the relatively modest net interest income.
  • Operating cash flow has remained positive and robust in recent quarters, supporting financial flexibility and ongoing distributions.
  • The insurer carries sizable insurance liabilities (claims, unearned premiums) that require ongoing reserve adequacy and prudent risk management; any deterioration could pressure profitability.
05/14/26 05:39 AM ETAI Generated. May Contain Errors.

Universal Insurance Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Universal Insurance's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Universal Insurance's net income appears to be on a downward trend, with a most recent value of $182.95 million in 2025, rising from $106.48 million in 2015. The previous period was $58.93 million in 2024. Find out what analysts predict for Universal Insurance in the coming months.

Over the last 10 years, Universal Insurance's total revenue changed from $546.54 million in 2015 to $1.60 billion in 2025, a change of 192.3%.

Universal Insurance's total liabilities were at $2.29 billion at the end of 2025, a 7.3% decrease from 2024, and a 226.7% increase since 2015.

In the past 10 years, Universal Insurance's cash and equivalents has ranged from $105.73 million in 2016 to $408.87 million in 2025, and is currently $408.87 million as of their latest financial filing in 2025.

Over the last 10 years, Universal Insurance's book value per share changed from 8.23 in 2015 to 19.65 in 2025, a change of 138.6%.



Financial statements for NYSE:UVE last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners